Research programme: leukaemia inhibitory factor variants - GenOdyssee
Alternative Names: GOLIFLatest Information Update: 16 Jul 2016
At a glance
- Originator GenOdyssee
- Class
- Mechanism of Action Leukaemia inhibitory factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in France
- 11 Apr 2006 Preclinical trials in HIV infections in France (unspecified route)